Samuel Takvorian, MD, MSHP Becomes Deputy Director of PC3I

November 15, 2024

The Penn Center for Cancer Care Innovation (PC3I) is pleased to announce the appointment of Samuel Takvorian, MD, MSHP as its next Deputy Director.

Dr. Takvorian, who is Assistant Professor of Medicine in the Division of Hematology and Oncology at the Perelman School of Medicine, joined PC3I in 2019 as Innovation Faculty and became Associate Director in 2022. With a clinical specialization in genitourinary malignancies and a research focus on clinical transformation and innovation in cancer care delivery, his work aims to improve the implementation of research findings into routine clinical practice. He currently serves as Director of PC3I’s Program in Patient-Generated Health Data, a role he will continue in his new capacity as Deputy Director.

During his time at PC3I, Dr. Takvorian has co-led many mission-aligned initiatives, including studies evaluating the effects of an augmented intelligence chatbot to improve symptom monitoring and oral chemotherapy adherence, and testing novel implementation strategies for promoting early serious illness conversations (SICs). He has also led impactful retrospective analyses evaluating the effect of state Medicaid policies on narrowing racial disparities in cancer care outcomes and clinical trial enrollment.

As PC3I’s Deputy Director, effective November 1, 2024, Dr. Takvorian will work to further PC3I’s mission to make cancer care better for patients, clinicians, and communities.